Found: 29
Select item for more details and to access through your institution.
Human wild‐type and D76N β<sub>2</sub>‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans.
- Published in:
- FASEB Bioadvances, 2023, v. 5, n. 11, p. 484, doi. 10.1096/fba.2023-00073
- By:
- Publication type:
- Article
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 6, p. 939, doi. 10.1515/cclm-2015-0985
- By:
- Publication type:
- Article
Biochemical markers in early diagnosis and management of systemic amyloidoses.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2014, v. 52, n. 11, p. 1517, doi. 10.1515/cclm-2014-0235
- By:
- Publication type:
- Article
Proteomics in protein misfolding diseases.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2009, v. 47, n. 6, p. 627, doi. 10.1515/CCLM.2009.164
- By:
- Publication type:
- Article
Renal amyloid‐A amyloidosis in cats: Characterization of proteinuria and biomarker discovery, and associations with kidney histology.
- Published in:
- Journal of Veterinary Internal Medicine, 2024, v. 38, n. 1, p. 205, doi. 10.1111/jvim.16920
- By:
- Publication type:
- Article
In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study.
- Published in:
- Scientific Reports, 2016, p. 29096, doi. 10.1038/srep29096
- By:
- Publication type:
- Article
A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in <i>E. coli</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0076022
- By:
- Publication type:
- Article
Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 3, p. 399, doi. 10.1007/s00277-011-1309-x
- By:
- Publication type:
- Article
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 1, p. 89, doi. 10.1007/s00277-011-1244-x
- By:
- Publication type:
- Article
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09133-w
- By:
- Publication type:
- Article
AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical Entity.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 80
- By:
- Publication type:
- Article
Protease‐sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
- Published in:
- FEBS Journal, 2022, v. 289, n. 2, p. 494, doi. 10.1111/febs.16182
- By:
- Publication type:
- Article
Treatment of IgM-associated AL amyloidosis with the combination of Rituximab, Bortezomib, and dexamethasone.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Treatment of IgM-Associated AL Amyloidosis With the Combination of Rituximab, Bortezomib, and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 143, doi. 10.3816/CLML.2011.n.033
- By:
- Publication type:
- Article
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.
- Published in:
- FASEB Journal, 2015, v. 29, n. 11, p. 4614, doi. 10.1096/fj.15-272179
- By:
- Publication type:
- Article
Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
- Published in:
- Proteomics, 2018, v. 18, n. 7, p. 1, doi. 10.1002/pmic.201700353
- By:
- Publication type:
- Article
Renal alterations in cats (Felis catus) housed in shelters and affected by systemic AA-amyloidosis: Clinicopathological data, histopathology, and ultrastructural features.
- Published in:
- Veterinary Pathology, 2024, v. 61, n. 5, p. 771, doi. 10.1177/03009858241257903
- By:
- Publication type:
- Article
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 4, p. 347, doi. 10.1007/s00277-008-0600-y
- By:
- Publication type:
- Article
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00355-6
- By:
- Publication type:
- Article
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 465, doi. 10.1002/ajh.23141
- By:
- Publication type:
- Article
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 699, doi. 10.3390/cells12050699
- By:
- Publication type:
- Article
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres.
- Published in:
- Molecules, 2021, v. 26, n. 7, p. 1913, doi. 10.3390/molecules26071913
- By:
- Publication type:
- Article
Malnutrition at Diagnosis Predicts Mortality in Patients With Systemic Immunoglobulin Light-Chain Amyloidosis Independently of Cardiac Stage and Response to Treatment.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2014, v. 38, n. 7, p. 891, doi. 10.1177/0148607113501328
- By:
- Publication type:
- Article
Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090916
- By:
- Publication type:
- Article
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
- Published in:
- Basic Research in Cardiology, 2013, v. 108, n. 5, p. 1, doi. 10.1007/s00395-013-0378-5
- By:
- Publication type:
- Article
Clinical proteomics for diagnosis and typing of systemic amyloidoses.
- Published in:
- Proteomics - Clinical Applications, 2013, v. 7, n. 1/2, p. 136, doi. 10.1002/prca.201200097
- By:
- Publication type:
- Article
Perspectives in developments of mass spectrometry for improving diagnosis and monitoring of multiple myeloma and other plasma cell disorders.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 11, p. 1734, doi. 10.1515/cclm-2016-1024
- By:
- Publication type:
- Article
Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycans.
- Published in:
- Protein Science: A Publication of the Protein Society, 2024, v. 33, n. 3, p. 1, doi. 10.1002/pro.4931
- By:
- Publication type:
- Article